Catalog No.: PC-24166Not For Human Use, Lab Use Only.
Opakalim (BHV-7000) is a potent, selective small molecule activator of Kv7.2/7.3 potassium channel with EC50 of 0.6 uM, shows minimal GABAA receptor activation, exhibits potent anti-seizure efficacy in the maximal electroshock seizure (MES) model.
Opakalim (BHV-7000) is a potent, selective small molecule activator of Kv7.2/7.3 potassium channel with EC50 of 0.6 uM, shows minimal GABAA receptor activation, exhibits potent anti-seizure efficacy in the maximal electroshock seizure (MES) model.
2. Pantet US20190284142 A1. 3. Bharat Awsare, et al. Phase 1 Study Evaluating the Safety and Tolerability of BHV-7000, a Novel, Selective Kv7.2/7.3 Potassium Channel Activator, in Healthy Adults (P8-1.007). April 9, 2024 issue.
